Semaglutide Dosing Explained: How Many Doses in Your Vial?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide comes in multi-dose vials designed to deliver weekly injections over several months, with doses gradually increasing to minimize side effects. Understanding how your vial is organized and what to expect during titration helps you plan your treatment timeline and manage expectations. PlexusDx compounded semaglutide injections are formulated in licensed 503A pharmacies and shipped ready to inject, with pricing that stays flat regardless of your dose level.

Understanding Semaglutide Vial Concentration and Supply

A standard semaglutide vial contains medication at a specific concentration—typically 2.4 mg per 1.5 mL for branded products, though compounded formulations may vary. The total amount in your vial determines how many weekly injections you can take before needing a refill. Most patients receive a 4-week supply at a time, which aligns with monthly billing cycles and ensures consistent access without extended storage concerns.

PlexusDx compounded semaglutide is prepared by licensed 503A pharmacies to match your prescribed concentration, allowing your provider to customize the supply duration based on your treatment phase. Whether you're in the initial titration phase (0.25 mg weekly) or maintenance (2.4 mg weekly), your vial contains the exact amount needed for your current stage. This approach eliminates waste and ensures you're always using fresh medication within the recommended timeframe.

The Standard 16-Week Semaglutide Titration Schedule

Most semaglutide protocols follow a predictable escalation pattern: Week 1–4 uses 0.25 mg weekly, Week 5–8 increases to 0.5 mg weekly, Week 9–12 moves to 1.0 mg weekly, and Week 13–16 reaches 1.7 mg weekly, with Week 17+ at the target maintenance dose of 2.4 mg weekly. This graduated approach gives your body time to adapt, reduces nausea and gastrointestinal side effects, and allows your provider to monitor how you respond before each increase. Each 4-week phase typically uses one vial or refill, making dosing intervals predictable and manageable.

Some patients may require a slower titration (20+ weeks) if they experience significant side effects, while others may remain at 1.7 mg or lower if they achieve their weight loss and metabolic goals without advancing further. PlexusDx providers personalize your titration based on your tolerance, baseline health status, and treatment response—your dose may increase, but your monthly price remains $149 flat, ensuring predictable costs throughout your journey.

How Many Injections Per Vial and Refill Timing

Because semaglutide is dosed once weekly, a typical 4-week supply vial contains exactly 4 injections for that phase. If your vial holds 1.5 mL and you're injecting 0.25 mL weekly during the first month, you'll use the entire vial in 4 weeks before receiving your next refill. This alignment between vial capacity and a monthly billing cycle simplifies adherence—you know when to expect your next shipment and never face gaps in treatment.

PlexusDx ships compounded semaglutide in quantities matched to your current dose phase, so refill timing coordinates with your provider's recommended escalation schedule. You'll receive your next dose adjustment and fresh vial supply on the same schedule, removing the need to calculate partial vials or manage leftover medication. This synchronized approach also reduces medication waste and ensures you're always using sterile, fresh product.

Personalizing Your Dose With Genetic and Clinical Insights

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many doses are in one semaglutide vial?

A standard 4-week supply vial contains 4 weekly injections matched to your current dose phase. PlexusDx ships compounded semaglutide in quantities timed to your provider's titration schedule, so you receive a fresh vial every month aligned with your dose increase.

What happens if I need to stay on the same dose longer than 4 weeks?

If your provider recommends extending a dose phase (for example, remaining on 0.5 mg for 8 weeks instead of 4), PlexusDx will adjust your supply accordingly. Your monthly price stays $189 flat regardless of whether you receive a single-dose or multi-dose vial.

Can I store a semaglutide vial longer than one month?

Compounded semaglutide should be used within the timeframe specified by your pharmacy (typically 30–60 days depending on formulation and storage). Once opened, the vial is good for 28 days when refrigerated at 2–8°C, so timing refills with your dose schedule prevents waste.

Does PlexusDx pricing change if I stay at a lower dose?

No. PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan flat across all commitment tiers—your dose may increase, but your price does not. This flat-rate model means you pay the same whether you're at 0.25 mg or 2.4 mg maintenance.

How does the Precision Peptide Genetic Test help with my dosing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide Dosing
• Medvi Semaglutide
• Bioverse Semaglutide
• Ro Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.